🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes

RecruitingNAAges 16 Years - 65 YearsAllEmory University
NCT07176988 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are: * To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes. * To determine the association between overall dysphonia outcomes and adoption of clear speech.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Non-smoking * Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions. * No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy) * No history of voice therapy or voice surgery in the last year * No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist, * Willingness to attend all therapeutic interventions and follow-up sessions * Willingness to use a smartphone to record practice Exclusion Criteria: * History of voice therapy or voice surgery in the last year * Serious chronic medical condition that may affect voice (per patient report) * Abnormal hearing ability (despite appropriate amplification) * Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions, * Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist * Unwillingness to attend therapeutic intervention and follow-up sessions * Unwillingness to use a smartphone to record practice * Pregnant women * Prisoners * Cognitive impairment or impaired decision-making capacity
💊

What it tests

  • Hierarchical method
  • Non Hierarchical method
📍

Where

1 site
Emory Voice Center at Emory University Hospital Midtown
Atlanta, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy